Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$44,898,866
-$14,236,229 QoQ
Shares Held
178,425
-34.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#397
of 4,150 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sterling Capital Management LLC holds $175,509,703 across 14 Drug Manufacturers - General names. ABBV ranks #2 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,980 | $64,745,235 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
178,425 | $44,898,866 | |
| 3 | AMGN |
Amgen Inc
|
58,377 | $21,139,478 | |
| 4 | MRK |
Merck & Co., Inc.
|
108,307 | $13,917,449 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
220,345 | $12,696,278 | |
| 6 | JNJ |
Johnson & Johnson
|
30,107 | $7,646,273 | |
| 7 | AZN |
Astrazeneca PLC
|
14,562 | $2,761,245 | |
| 8 | NVO |
Novo Nordisk A S
|
49,472 | $2,371,687 |
All Filings in ABBV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,898,866 | 178,425 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $59,135,095 | 271,898 | Shares | Defined | 2026-04-22 | |
| 2025-12-31 | $63,004,060 | 275,741 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $96,363,937 | 416,187 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $86,724,819 | 467,217 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $93,432,091 | 445,934 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $83,716,780 | 471,113 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $143,103,289 | 724,647 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||